{"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"unavailable","subject":"alpha:company:scribe-therapeutics-inc","as_of":"unavailable","recorded_at":"unavailable","availability":"unavailable","records":[],"next_offset":null,"limitations":["Structured intelligence is not currently available. Existing published profile evidence remains accessible."]},"protocol_version":"0.1","schema_version":"alpha.governance.entity.public.v1","record_version":"public-1","entity":{"id":"alpha:company:6470d65d-a22c-4860-84cc-2989c9aa2914","type":"Company","slug":"scribe-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/scribe-therapeutics-inc","legal_name":"Scribe Therapeutics, Inc.","display_name":"Scribe Therapeutics, Inc.","aliases":[]},"publication":{"state":"PUBLISHED","published_at":"2026-10-05T04:46:28.195424+00:00","observed_at":"2026-10-05T04:46:28.195424+00:00","reviewed_at":"2026-10-05T04:46:28.195424+00:00","verified_at":"2026-10-05T04:46:28.195424+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/scribe-therapeutics-inc","media_type":"text/html"},"markdown":{"href":"https://registry.alpha.ac/companies/scribe-therapeutics-inc.md","media_type":"text/markdown"},"json":{"href":"https://registry.alpha.ac/api/public/companies/scribe-therapeutics-inc?format=record","media_type":"application/json"},"jsonld":{"href":"https://registry.alpha.ac/api/public/companies/scribe-therapeutics-inc?format=jsonld","media_type":"application/ld+json"},"api":{"href":"https://registry.alpha.ac/api/public/companies/scribe-therapeutics-inc","media_type":"application/json"},"mcp":{"uri":"alpha://companies/scribe-therapeutics-inc","endpoint":"https://mcp.alpha.ac/mcp","media_type":"application/json"}},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":2,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":2,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-10-05T04:46:28.195424+00:00","observed_at":"2026-10-05T04:46:28.195424+00:00","freshness_days":0}},"claims":[{"id":"alpha:claim:company:6470d65d-a22c-4860-84cc-2989c9aa2914:legal_name:1","subject_id":"alpha:company:6470d65d-a22c-4860-84cc-2989c9aa2914","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Scribe Therapeutics, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"Scribe Therapeutics, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T04:46:28.195424+00:00","sources":[{"id":"alpha:projection-evidence:3e1334bb172546c494fc8c61c50a5f6dd6329186159c7872eee6cdbe8cab4908","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/scribe-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-05T04:46:28.195424+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T04:46:28.195424+00:00","reviewed_at":"2026-10-05T04:46:28.195424+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:6470d65d-a22c-4860-84cc-2989c9aa2914:entity_status:3","subject_id":"alpha:company:6470d65d-a22c-4860-84cc-2989c9aa2914","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Listing not asserted","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Listing not asserted","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T04:46:28.195424+00:00","sources":[{"id":"alpha:projection-evidence:3e1334bb172546c494fc8c61c50a5f6dd6329186159c7872eee6cdbe8cab4908","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/scribe-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-05T04:46:28.195424+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T04:46:28.195424+00:00","reviewed_at":"2026-10-05T04:46:28.195424+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:6470d65d-a22c-4860-84cc-2989c9aa2914:published_fact:4","subject_id":"alpha:company:6470d65d-a22c-4860-84cc-2989c9aa2914","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T04:46:28.195424+00:00","sources":[{"id":"alpha:projection-evidence:3e1334bb172546c494fc8c61c50a5f6dd6329186159c7872eee6cdbe8cab4908","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/scribe-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-05T04:46:28.195424+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-05T04:46:28.195424+00:00","reviewed_at":"2026-10-05T04:46:28.195424+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:6470d65d-a22c-4860-84cc-2989c9aa2914:leadership_role:5","subject_id":"alpha:company:6470d65d-a22c-4860-84cc-2989c9aa2914","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:benjamin-l-oakes","object_label":null,"object_source_name_forms":[],"value":"Benjamin L. Oakes: Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Benjamin L. Oakes: Chairman of the Board","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T04:46:28.195424+00:00","sources":[{"id":"alpha:projection-evidence:document:85ad6c13412cc7b1bf16877c5737b5e0dcbfc961fca79ccc0bfcb2b300cd92bd","identity_scope":"source_document_reference","source_type":"issuer_ir","title":"Issuer IR scribe-therapeutics-inc","publisher":null,"url":"https://investors.scribetx.com/corporate-governance/committee-composition","source_date":"2026-09-14T00:00:00+00:00","retrieved_at":"2026-09-14T14:00:21.312876+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-09-14T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-05T04:46:28.195424+00:00","reviewed_at":"2026-10-05T04:46:28.195424+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:6470d65d-a22c-4860-84cc-2989c9aa2914:leadership_role:6","subject_id":"alpha:company:6470d65d-a22c-4860-84cc-2989c9aa2914","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:behzad-aghazadeh","object_label":null,"object_source_name_forms":[],"value":"Behzad Aghazadeh: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Behzad Aghazadeh: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T04:46:28.195424+00:00","sources":[{"id":"alpha:projection-evidence:document:85ad6c13412cc7b1bf16877c5737b5e0dcbfc961fca79ccc0bfcb2b300cd92bd","identity_scope":"source_document_reference","source_type":"issuer_ir","title":"Issuer IR scribe-therapeutics-inc","publisher":null,"url":"https://investors.scribetx.com/corporate-governance/committee-composition","source_date":"2026-09-14T00:00:00+00:00","retrieved_at":"2026-09-14T14:00:21.312876+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-09-14T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-05T04:46:28.195424+00:00","reviewed_at":"2026-10-05T04:46:28.195424+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:6470d65d-a22c-4860-84cc-2989c9aa2914:leadership_role:7","subject_id":"alpha:company:6470d65d-a22c-4860-84cc-2989c9aa2914","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:carl-gordon","object_label":null,"object_source_name_forms":[],"value":"Carl Gordon: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Carl Gordon: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T04:46:28.195424+00:00","sources":[{"id":"alpha:projection-evidence:document:85ad6c13412cc7b1bf16877c5737b5e0dcbfc961fca79ccc0bfcb2b300cd92bd","identity_scope":"source_document_reference","source_type":"issuer_ir","title":"Issuer IR scribe-therapeutics-inc","publisher":null,"url":"https://investors.scribetx.com/corporate-governance/committee-composition","source_date":"2026-09-14T00:00:00+00:00","retrieved_at":"2026-09-14T14:00:21.312876+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-09-14T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-05T04:46:28.195424+00:00","reviewed_at":"2026-10-05T04:46:28.195424+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:6470d65d-a22c-4860-84cc-2989c9aa2914:leadership_role:8","subject_id":"alpha:company:6470d65d-a22c-4860-84cc-2989c9aa2914","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-watson-scribe-therapeutics-inc","object_label":null,"object_source_name_forms":[],"value":"James Watson: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"James Watson: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T04:46:28.195424+00:00","sources":[{"id":"alpha:projection-evidence:document:85ad6c13412cc7b1bf16877c5737b5e0dcbfc961fca79ccc0bfcb2b300cd92bd","identity_scope":"source_document_reference","source_type":"issuer_ir","title":"Issuer IR scribe-therapeutics-inc","publisher":null,"url":"https://investors.scribetx.com/corporate-governance/committee-composition","source_date":"2026-09-14T00:00:00+00:00","retrieved_at":"2026-09-14T14:00:21.312876+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-09-14T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-05T04:46:28.195424+00:00","reviewed_at":"2026-10-05T04:46:28.195424+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:6470d65d-a22c-4860-84cc-2989c9aa2914:leadership_role:9","subject_id":"alpha:company:6470d65d-a22c-4860-84cc-2989c9aa2914","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:joshua-bleharski","object_label":null,"object_source_name_forms":[],"value":"Joshua Bleharski: Lead Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Joshua Bleharski: Lead Independent Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T04:46:28.195424+00:00","sources":[{"id":"alpha:projection-evidence:document:85ad6c13412cc7b1bf16877c5737b5e0dcbfc961fca79ccc0bfcb2b300cd92bd","identity_scope":"source_document_reference","source_type":"issuer_ir","title":"Issuer IR scribe-therapeutics-inc","publisher":null,"url":"https://investors.scribetx.com/corporate-governance/committee-composition","source_date":"2026-09-14T00:00:00+00:00","retrieved_at":"2026-09-14T14:00:21.312876+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-09-14T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-05T04:46:28.195424+00:00","reviewed_at":"2026-10-05T04:46:28.195424+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:6470d65d-a22c-4860-84cc-2989c9aa2914:leadership_role:10","subject_id":"alpha:company:6470d65d-a22c-4860-84cc-2989c9aa2914","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:benjamin-l-oakes","object_label":null,"object_source_name_forms":[],"value":"Benjamin L. Oakes: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Benjamin L. Oakes: President and Chief Executive Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-05T04:46:28.195424+00:00","sources":[{"id":"alpha:projection-evidence:document:85ad6c13412cc7b1bf16877c5737b5e0dcbfc961fca79ccc0bfcb2b300cd92bd","identity_scope":"source_document_reference","source_type":"issuer_ir","title":"Issuer IR scribe-therapeutics-inc","publisher":null,"url":"https://investors.scribetx.com/corporate-governance/committee-composition","source_date":"2026-09-14T00:00:00+00:00","retrieved_at":"2026-09-14T14:00:21.312876+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-09-14T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-05T04:46:28.195424+00:00","reviewed_at":"2026-10-05T04:46:28.195424+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"}],"evidence":[{"id":"alpha:projection-evidence:3e1334bb172546c494fc8c61c50a5f6dd6329186159c7872eee6cdbe8cab4908","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/scribe-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-05T04:46:28.195424+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:85ad6c13412cc7b1bf16877c5737b5e0dcbfc961fca79ccc0bfcb2b300cd92bd","identity_scope":"source_document_reference","source_type":"issuer_ir","title":"Issuer IR scribe-therapeutics-inc","publisher":null,"url":"https://investors.scribetx.com/corporate-governance/committee-composition","source_date":"2026-09-14T00:00:00+00:00","retrieved_at":"2026-09-14T14:00:21.312876+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage":{"identity":"PUBLISHED","business":"PUBLISHED","leadership":"PUBLISHED","board_and_committees":"PUBLISHED","governance":"NOT_ASSERTED","financials":"NOT_ASSERTED","workforce":"NOT_ASSERTED","ownership":"NOT_ASSERTED","ratings":"NOT_PUBLISHED","market_and_index_context":"NOT_REVIEWED"},"representation_version":"alpha-governance-record-v2","role_modules":[],"attention":[],"committee_data":[],"quality":{"schema_version":"alpha-record-quality-v1","overall":0.818,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.425,"freshness":1,"evidence_completeness":1,"source_authority":0.717,"cross_source_agreement":0.75},"diagnostics":{"published_claims":9,"factual_claims":9,"claims_with_linked_evidence":9,"disputed_claims":0,"stale_claims":0,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings","market_and_index_context"]},"derivation":"deterministic_record_projection"}}